Amphetamine sensitization: Nonassociative and associative components

Behavioral Neuroscience

Volumn 117, Issue 5, 2003, Pages 961-969

  Wang, Ying Chou ^a,c   Hsiao, Sigmund ^a,b  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHING KUO INSTITUTE OF MANAGEMENT AND HEALTH   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CHLORAL HYDRATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; CONDITIONING; CONTROLLED STUDY; DRUG WITHDRAWAL; LOCOMOTION; MALE; NERVE CELL STIMULATION; NONHUMAN; RAT; SENSITIZATION;

AMPHETAMINE; ANIMALS; ASSOCIATION LEARNING; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0141954095     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.117.5.961     Document Type: Article

References (27)

1. Anagnostaras, S. G., Gale, G. D., & Fanselow, M. S. (2001). Hippocampus and contextual fear conditioning: Recent controversies and advances. Hippocampus, 11, 8-17.
2. Anagnostaras, S. G., & Robinson, T. E. (1996). Sensitization to the psychomotor stimulant effects of amphetamine: Modulation by associative learning. Behavioral Neuroscience, 110, 1397-1414.
3. Anagnostaras, S. G., Schallert, T., & Robinson, T. E. (2002). Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology, 6, 703-715.
4. Arvanitogiannis, A., Sullivan, J., & Amir, S. (2002). Time acts as a conditioned stimulus to control behavioral sensitization to amphetamine in rats. Neuroscience 101, 1-3.
5. Battisti, J. J., Chang, C. H., Uretsky, N. J., & Wallace, L. J. (1998). Sensitization of stereotyped behavior to amphetamine is context and response dependent. Pharmacology Biochemistry and Behavior, 63, 263-269.
6. Battisti, J. J., Uretsky, N. J., & Wallace, L. J. (2000). Importance of environmental context in the development of amphetamine- or apomorphine-induced stereotyped behavior after single and multiple doses. Pharmacology Biochemistry and Behavior, 66, 671-677.
7. Castaneda, E., Becker, J. B., & Robinson, T. E. (1988). The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KCl and electrical stimulation-evoked striatal dopamine release in vitro. Life Sciences, 42, 2447-2456.
8. Ellinwood, E. H., & Balster, R. L. (1974). Rating the behavioral effects of amphetamine. Pharmacology, 28, 35-41.
9. Fanselow, M. S. (2000). Contextual fear, gestalt memories, and the hippocampus. Behavioural Brain Research, 110, 73-81.
10. Huang, A. C. W., & Hsiao, S. (2002). Haloperidol attenuates rewarding and aversively conditioned suppression of saccharin solution intake: Reevaluation of the anhedonia hypothesis of dopamine blocking. Behavioral Neuroscience, 116, 646-650.
11. Huang, Y. H., Tsai, S. J., Wang, Y. C., Yu, M. F., Yang, Y. C., & Sim, C. B. (1997). Differential development of the enhanced metabolic response during amphetamine sensitization. Neuropsychobiology, 36, 177-181.
12. Huang, Y. H., Tsai, S. J., Yu, M. F., Wang, Y. C., Yang, Y. C., & Sim, C. B. (1995). Dose-dependent effects of chronic amphetamine administration in local cerebral glucose utilization in rat. Neuropsychobiology, 32, 149-155.
13. LeDoux, J. E. (1996). The emotional brain: The mysterious underpinnings of emotional life (1st ed.). New York: Simon & Schuster.
14. Pan, H. T., Lai, Y. J., & Chen, N. H. (1995). Differential effects of chloral hydrate and pentobarbital sodium on cocaine level and its catecholamine response in the medial prefrontal cortex: A comparison with conscious rats. Journal of Neurochemistry, 64, 2653-2659.
15. Piazza, P. V., Deminiere, J. M., Moal, M. L., & Simon, H. (1989, September 29). Factors that predict individual vulnerability to amphetamine self-administration. Science, 245, 1511-1513.
16. Pierce, R. C., & Kalivas, P. W. (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research Reviews, 25, 192-216.
17. Robinson, T. E. (1984). Behavioral sensitization: Characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology, 84, 466-475.
18. Robinson, T. E., & Becker, J. B. (1982). Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. European Journal of Pharmacology, 85, 253-254.
19. Robinson, T. E., & Becker, J. B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Research Reviews, 11, 157-198.
20. Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18, 247-291.
21. Robinson, T. E., & Kolb, B. (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. Journal of Neuroscience, 17, 8491-8497.
22. Rudy, J. W., & O'Reilly, R. C. (1999). Contextual fear conditioning, conjunctive representations, pattern completion, and the hippocampus. Behavioral Neuroscience, 113, 867-880.
23. Schultz, W., Dayan, P., & Montague, P. R. (1997, March 14). A neural substrate of prediction and reward. Science, 275, 1593-1599.
24. Segal, D., & Kuczenski, R. (1987). Individual differences in responsiveness to single and repeated amphetamine administration: Behavioral characteristics and neurochemical correlates. Journal of Pharmacology and Experimental Therapeutics, 242, 917-926.
25. Segal, D. S., & Mandell, A. J. (1974). Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypy. Pharmacology Biochemistry and Behavior, 2, 249-255.
26. Stewart, J., & Badiani, A. (1993). Tolerance and sensitization to the behavioral effects of drugs. Behavioural Pharmacology, 4, 289-312.
27. Stewart, J., & Vezina, P. (1991). Extinction procedures abolish conditioned stimulus control but spare sensitized responding to amphetamine. Behavioural Pharmacology, 2, 65-71.